Defunct Company
Total Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
119
NCT00417274
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: May 31, 2008
NCT00574483
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
Start: Nov 30, 2007
Completion: Jan 31, 2008
NCT01527136
Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Phase: Phase 1
Role: Collaborator
Start: Jan 31, 2012
Completion: Oct 31, 2014
NCT01728480
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
Start: Jan 31, 2014
Completion: Not specified
NCT02715882
Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer
Start: Nov 30, 2015
Completion: Dec 31, 2017
NCT02778763
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
Start: Dec 31, 2015
Completion: Jul 31, 2016